AVR 2.97% $12.15 anteris technologies ltd

Credit Suisse Research Report, page-12

  1. 3,158 Posts.
    lightbulb Created with Sketch. 249
    I believe that it is essential that we enter into agreement with potential strategic partners if we are going to penetrate the market for our products. I think a previous poster on one of these threads described dealing with the major pharmas as being like doing business with the mafia. I have just been reading an article on the penalties dished out to Novartis for their doctor kickback scheme and I agree with the sentiment. Link to the article hereunder -
    https://www.fiercepharma.com/pharma/novartis-former-sales-rep-gets-109m-for-blowing-whistle-doctor-kickbacks?mkt_tok=eyJpIjoiTmpObFlURTJObVEzWTJFdyIsInQiOiJ2MUY4UTlQQXU5NGNHSHJxZmNCcEw0RU94UkwxUDczMGhvWlE5UFRwbStqQlRZbGowSmVpR1RTbStYWDhYVHRoXC9GU3VVaE9Zc09BbVVlMjBXREo1QUVsa3ZtNDAxYWF6bjlpb1VyOXp5VG9vYTRadU56Ymc0XC9VdFg3VlpxbklySTE1YWVtczNiNEVxT2VoYVZ5SzdoQT09In0%3D&mrkid=61404167
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$12.15
Change
0.350(2.97%)
Mkt cap ! $256.8M
Open High Low Value Volume
$11.80 $12.15 $11.21 $376.0K 32.22K

Buyers (Bids)

No. Vol. Price($)
3 139 $12.00
 

Sellers (Offers)

Price($) Vol. No.
$12.15 830 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.